Clearance Summary
BioZorb SP Marker received FDA 510(k) clearance under submission number K192371, sponsored by Focal Therapeutics. The device was reviewed via the Special premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2019-09-26.
- Submission: K192371
- Applicant / Sponsor: Focal Therapeutics
- Clearance pathway: Special
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4300
- Decision date: 2019-09-26
Classification & Regulation
This clearance is catalogued under FDA product code NEU and 21 CFR 878.4300, within the General, Plastic Surgery review panel as a Class II device.